The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO)

NCT07367880 | Recruiting

• 2 other identifiers: 38RC25.0190_TeDIMO2025-A01292-47
• Study Type: observational
• Target: 220
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this study is to show a significant difference in performance between 2 groups of participants (healthy elderly people vs. people with Alzheimer Disease) in an identification and naming task involving famous monuments.

Conditions

Alzheimer s Disease

Keywords

unique entities; denomination; identification; landmarks

Outcome Measures

Primary Outcomes (1)

• Difference between the two groups in the identification and naming task involving famous landmarks

  show a significant difference in performance between the two groups in the identification and naming task involving famous landmarks

  1 month

Secondary Outcomes (1)

• Development and standardization of a new tool for screening for naming disorders and visual identification of unique entities.

  5 years

Study Arms (2)

People with Alzheimer Disease

Other: Identification and naming task

Healthy elderly people

Other: Identification and naming task

Interventions

Identification and naming task OTHER

Task of identification and naming of landmarks and celebrities

Healthy elderly people; People with Alzheimer Disease

Eligibility Criteria

• Age: 50 Years - 95 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Participants in the MA group will be selected from among patients attending memory consultations at the CMRR at the CHU Grenoble-Alpes (active file within the department) or from among patients referred to the CMRR by a doctor not practicing at the CMRR (general practitioners or specialists such as neurologists). Healthy elderly participants will be recruited from among those accompanying patients being monitored at the CMRR.

You may qualify if:

• Alzheimer's disease:
• Age ≥ 50 years and older
• Possible or probable diagnosis of Alzheimer's disease according to the revised criteria of Mac Khann et al., 2011.
• Score 18≤ MMSE ≤26
• Controls:
• Age ≥ 50 years and older
• MMSE score ≥ 26 For all subjects
• No objection from the participant

You may not qualify if:

• Alzheimer's disease:
• Persons referred to in Articles L1121-5 to L1121-8 of the CSP
• Controls:
• Memory complaints
• Persons referred to in Articles L1121-5 to L1121-8 of the CSP For all subjects
• Significant neurological or psychiatric history
• Taking psychotropic medication (neuroleptics)
• Poor command of the French language, comprehension difficulties
• Significant hearing or visual impairments (diplopia, nystagmus, scotoma, etc.)
• Insufficient exposure to the media and/or socio-cultural knowledge (questionnaire) ; Deficit in face recognition (Benton Face Recognition Test)

Sponsors & Collaborators

• University Hospital, Grenoble: lead

Study Sites (1)

CHU Grenoble Alpes

Grenoble, France

RECRUITING

Central Study Contacts

Sabrina Iannuzzi, Neuropsychologist

CONTACT

+334.76.76.57.90; siannuzzi@chu-grenoble.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 1 Month
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 15, 2025
• First Posted: January 26, 2026
• Study Start: February 23, 2026
• Primary Completion (Estimated): February 1, 2031
• Study Completion (Estimated): February 1, 2032
• Last Updated: May 26, 2026

Record last verified: 2026-05

Locations

FR (1)